QUEENSBURY, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease, announced today that it will present at the Canaccord Adams 28th Annual Global Growth Conference in Boston, MA on Thursday, August 14, 2008. Eamonn Hobbs, President and CEO of AngioDynamics, will present a review of the Company’s business strategy and historical financial results at 11:30 a.m. Eastern Time.
